Biofrontera (BFRI) Operating Leases (2022 - 2025)

Biofrontera's Operating Leases history runs 4 years deep, the most recent figure standing at $1.2 million for Q4 2025.

• On a quarterly basis, Operating Leases rose 349.28% year-over-year to $1.2 million in Q4 2025; TTM through Dec 2025 was $1.2 million, a 349.28% increase from a year earlier, with the FY2025 full-year figure at $1.2 million, up 349.28% from the prior year.
• Operating Leases advanced to $1.2 million in Q4 2025 per BFRI's latest filing, from $136000.0 in the prior quarter.
• Across five years, Operating Leases topped out at $1.2 million in Q4 2025 and bottomed at $136000.0 in Q3 2025.
• The 4-year median for Operating Leases is $502500.0 (2023), against an average of $535166.7.
• Across the five-year window, Operating Leases plunged 65.67% in 2024 and surged 349.28% in 2025, its largest moves.
• Year by year, Operating Leases stood at $848000.0 in 2022, then dropped by 5.19% to $804000.0 in 2023, then plunged by 65.67% to $276000.0 in 2024, then soared by 349.28% to $1.2 million in 2025.
• Per Business Quant, the three latest BFRI Operating Leases figures stand at $1.2 million (Q4 2025), $136000.0 (Q3 2025), and $223000.0 (Q2 2025).